You are here: Industry Insights > spike protein

News List

Three exposures to spike protein allow people to develop broad antibody immunity - also against Omicron WorldPharmaNews
February 07, 2022
Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total of three exposures to the viral spike protein.
Sino Biological newly launched a panel of research reagents for SARS-CoV-2 Omicron variant prnasia
December 08, 2021
Sino Biological, Inc. (http://www.sinobiological.com; SHE: 301047) announced today that it has launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-COV-2 virus...
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations prnasia
December 07, 2021
Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale for its potential to address the Omicron...
The drug aprotinin inhibits entry of SARS-CoV2 in host cells worldpharmanews
November 26, 2020
The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell.
Locking down shape-shifting spike protein aids development of COVID-19 vaccine worldpharmanews
August 06, 2020
The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein that mimics ...